KING'S CLINICAL TRIALS UNIT

Previous
Next

Our mission at King’s Clinical Trials Unit is to assure excellence, efficiency and transparency in the design, conduct, analysis and reporting of clinical trials, for the benefit of patients and society.

KCTU is formed of collaborative academic and operational teams, supporting a portfolio of high-quality clinical trials. Centralised expertise streamlines delivery of the most complex aspects of trials.

QUICK LINKS

Tweets by @kclctu

The BEACON trial is comparing, for the first time, three key systemic treatments (taken by mouth or injection) for severe adult eczema. For more information on recruiting sites and to register your interest, visit http://www.beacontrial.org

The results from the APIPPRA trial led by KCL, published in The Lancet, provide hope for arthritis sufferers after it was shown that the biologic drug abatacept reduces progression to this agonising chronic inflammatory disease. Read more here:

Load More

COLLABORATE WITH US

To collaborate with KCTU, a brief support request form must be submitted.

We strongly advise that researchers approach KCTU at the grant application stage, ideally 3-4 months in advance of the submission deadline to get the best possible input and consideration.

Requests for support are circulated to the relevant senior academic and operational staff for consideration, to ensure that the best possible match between the trial and the expert collaborator is achieved.

NIHR TRIALS

KING'S CLINICAL TRIALS UNIT

The King’s CTU has been awarded full CTU registration by the UKCRC

KING'S CLINICAL TRIALS UNIT

This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.